Innovation Theater Lunch (non-CME): Addressing the Clinical Challenges of Treating VLUs and DFUs after 4 Weeks of Conventional Care: An Evidence-based Approach to Accelerate Healing with the Only Product FDA-approved to Heal both VLUs and DFUs
This Satellite Symposium non-CME presentation is held in conjunction with the SAWC Fall 2023 Meeting. The opinions and recommendations expressed do not necessarily reflect the view of HMP Education or SAWC. This program is not intended or eligible for continuing education (CME/CE) credits and does not meet guidelines governing CME/CE.
Learning Objectives:
Discuss the prognostic indicators for treating hard-to-heal DFUs and VLUs after utilizing conventional care
Explore the outcomes of a mechanism of action study proven to stimulate wound-edge keratinocytes to activate an acute wound healing response
Review the real-world evidence demonstrating the reliability of Apligraf in patient populations outside of highly controlled RCTs